Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection

Abstract excerpt

BACKGROUND: The grim (<10% 5-year) survival rates for pancreatic ductal adenocarcinoma (PDAC) are attributed to its complex intrinsic biology and most often late-stage detection. The overlap of symptoms with benign gastrointestinal conditions in early stage further complicates timely detection. The suboptimal diagnostic performance of carbohydrate antigen (CA) 19-9 and elevation in benign hyperbilirubinaemia...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to AI in cancer detection
• Share to Pancreatic and Hepatic Oncology Research
• Share to Pancreatitis Pathology and Treatment